Cancer Letters
Volume 205, Issue 2 , Page 229, 18 March 2004

Corrigendum to ‘Comparative mutagenicities of bleomycin and ferric-nitrilotriacetate in lacZ mice’ [Cancer Letters 187 (2002) 41–46]☆

  • Wieslawa Kosinska

      Affiliations

    • Department of Basic Sciences, New York University, Dental Center, 345 East 24th Street, New York, NY 10100, USA
    • ,
  • Edward Pelle

      Affiliations

    • Department of Biology, New York University, New York, NY 10012, USA
    • ,
  • Marcia d.M. von Pressentin

      Affiliations

    • Department of Basic Sciences, New York University, Dental Center, 345 East 24th Street, New York, NY 10100, USA
    • ,
  • Michael Chen

      Affiliations

    • Department of Basic Sciences, New York University, Dental Center, 345 East 24th Street, New York, NY 10100, USA
    • ,
  • Joseph B. Guttenplan

      Affiliations

    • Department of Basic Sciences, New York University, Dental Center, 345 East 24th Street, New York, NY 10100, USA
    • Department of Environmental Medicine, New York University, Medical Center, New York, NY 10016, USA
    • Corresponding Author InformationCorresponding author. Address: Division of Basic Sciences/Biochemistry, New York University, Dental Center, 345 East 24th Street, New York, NY 10100, USA. Tel.: +1-212-998-9604; fax: +1-212-995-4087

Article Outline

     

    The authors regret that in the original printing of the above-mentioned article, Fig. 1, Fig. 2 were printed incorrectly. They are now reproduced in their correct form below.

    • View full-size image.
    • Fig. 1. 

      Mean mutant fractions (in units of mutants/105 plaque-forming units) in kidney, liver and lung of male lacZ mice (MutaMouse) administered total doses of Fe-NTA of 0, 3.75, 27 or 35 mg Fe/kg body weight followed by a 3-week expression period. Results are expressed as a group mean±SD. n=3 for each of the Fe-NTA-treated groups and n=6 for the control group. At least 15 mutants/tissue were assayed for each animal. None of the differences was significant.

    • View full-size image.
    • Fig. 2. 

      Mean mutant fractions (in units of mutants/105 plaque-forming units) in kidney, liver and lung of male lacZ mice (MutaMouse) administered one or two 20 mg/kg body weight i.p. doses of bleomycin sulfate followed by a 3-week expression period. Results are expressed as a group mean±SD. n=3 for each of the bleomycin-treated groups and n=6 for the control group. At least 30 mutants/tissue were assayed for each animal. *P<0.05, **P<0.01 vs. the corresponding control in a two-tailed Student's t-test.

☆ Some of these results were presented at the Eighth International Conference on Environmental Mutagens, Shizuoka, Japan, October 21–26, 2001.

PII: S0304-3835(03)00712-2

doi:10.1016/j.canlet.2003.10.015

Refers to article:

  • Comparative mutagenicities of bleomycin and ferric-nitrilotriacetate in lacZ mice

    Wieslawa Kosinska, Edward Pelle, Marcia d.M. von Pressentin, Michael Chen, Joseph B. Guttenplan
    Cancer Letters 10 December 2002 (Vol. 187, Issue 1, Pages 41-46)

Cancer Letters
Volume 205, Issue 2 , Page 229, 18 March 2004

Article Tools

* Image Usage & Resolution